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Background: EAACI guidelines emphasize the importance of patient history in diag-
nosing food allergy (FA) and the need for studies investigating its value using stand-
ardized allergy-focused questionnaires.
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1  | INTRODUC TION
Typical food allergies (FAs) are IgE-mediated. In some parts of Europe, 
the prevalence of self-reported FA to commonly incriminated foods 
is as high as 19% in adults and 25% in school-age children from the 
general population.1,2 The majority of these self-reported adverse 
reactions to foods are however not attributed to IgE: the prevalence 
of probable FA, defined as a food-specific case history supported 
by relevant IgE sensitization, is much lower than the prevalence of 
self-reported FA.1-3
A key tool available to all physicians for assessing the likelihood 
of FA is patient history. FA guidelines from the European Academy 
of Allergy and Clinical Immunology (EAACI) acknowledge the impor-
tance of patient history in the diagnosis of FA, but also highlight that 
studies evaluating the accuracy of predictions using standardized 
allergy-focused history questionnaires are lacking, as well as stud-
ies modelling the use of history to predict FA.4 Current evidence is 
based on expert opinion.4,5 Therefore, the EAACI guidelines have 
assigned high priority to clinical studies investigating this knowledge 
gap.4
The data collected using well-standardized questionnaires in the 
EU-funded multicenter EuroPrevall project, designed to evaluate FA 
across Europe, provide a unique opportunity to investigate the value 
of information available from patient history for predicting FA. The 
objective of this study was to ascertain which reaction character-
istics, allergic comorbidities and demographic factors contribute to 
prediction of probable FA in adults and school-age children report-
ing food-related symptoms.
2  | METHODS
2.1 | Study design, setting and subjects
As part of the EuroPrevall project, data were collected between 
2005 and 2009 from 20- to 54-year-old and 7- to 10-year-old ran-
domly sampled individuals from the general population of socio-eco-
nomically and climatically different regions in Europe. The detailed 
methodology of this study is described elsewhere.2,3,6 The study 
population for the current study consisted of subjects with self-
reported FA from Athens (Greece), Lodz (Poland), Madrid (Spain), 
Reykjavik (Iceland), Utrecht (the Netherlands), Vilnius (Lithuania) 
and Zurich (Switzerland). Subjects responded to a short screening 
questionnaire on adverse reactions to food, symptoms and incrimi-
nated foods, in phase I of the EuroPrevall study. Subjects were fur-
ther evaluated in phase II if they indicated that they had symptoms 
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to one of 24 foods frequently consumed or commonly implicated in 
food allergic reactions across Europe (so-called priority foods: hen's 
egg, cow's milk, fish, shrimp, peanut, hazelnut, peach, apple, cel-
ery, walnut, soy, wheat, buckwheat, kiwi fruit, corn, carrot, tomato, 
melon, banana, lentils, sesame seed, mustard seed, sunflower seed 
and poppy seed). Phase II consisted of an extensive questionnaire 
and blood sampling to test for presence of IgE against priority foods. 
All subjects with self-reported symptoms to one of the 24 priority 
foods, a completed phase II questionnaire and IgE serology testing, 
were included in this study.2,3
The local ethical committees of all participating centers approved 
this study, and informed consent was obtained from all participants.
2.2 | Data collection
The outcome, probable FA, was considered present in subjects with 
IgE sensitization corresponding to a self-reported adverse reac-
tion to at least one of the 24 priority foods. Commercially available 
ImmunoCAP tests (Phadia, currently Thermo Fisher Scientific) were 
used to measure serum sIgE levels, and a value ≥0.35 kUA/L was 
considered positive. All serology testing was performed in a single 
laboratory at the Amsterdam University Medical Centers (location 
AMC, Amsterdam, the Netherlands).
The evaluated predictors were as follows: reaction character-
istics (time until onset, reproducibility of the reaction, oral allergy 
symptoms [OAS], skin symptoms, gastrointestinal symptoms, rhino-
conjunctivitis, respiratory symptoms and cardiovascular symptoms); 
allergic comorbidities (allergic rhinitis [AR], asthma, atopic dermatitis 
[AD]); demoghraphic factors (age, sex, [parental] level of education); 
and (parental) smoking. The predictor information was obtained 
from both the phase I and phase II questionnaires, which were en-
riched versions of well-standardized allergy questionnaires,7 with a 
specific focus on reactions to the priority foods. The phase I ques-
tionnaire was self-administered, while the phase II questionnaire 
was conducted by trained interviewers.
2.3 | Data analysis
Analyses were performed separately for adults and children. 
Differences between subjects with and without probable FA were 
G R A P H I C A L  A B S T R A C T
In support of expert opinion, data collected in a standardized manner all across Europe reveal that information available from patient history 
can accurately predict IgE sensitization corresponding to a food-specific case history (probable FA). OAS and AR comorbidity are strongly 
associated with presence of FA and GI symptoms with absence of FA (particularly plant FA) in adults and children.
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described and analyzed using the chi-square test, two-sample T test 
or Mann-Whitney U test, as appropriate for the variable's distribu-
tion. After obtaining crude odds ratios (ORs) for each of the evalu-
ated predictors through univariable logistic regression, multivariable 
logistic regression was performed with all predictors to determine 
adjusted ORs. Because the probability of probable FA is known to 
differ per center,2,3 center was included as a covariate in the analysis. 
The Lithuanian site Vilnius was only included in the pediatric popu-
lation, as very few (N = 4) Lithuanian adults with self-reported FA 
participated in phase II.3
In order to present a parsimonious model with the most discrim-
inative combination of the evaluated predictors for probable FA, 





Probable FA No probable FA Probable FA No probable FA
N = 207 N = 637 N = 136 N = 534
Age, mean (SD) 35.9 (9.0) 37.8 (9.5) .012 9.02 (0.99) 8.88 (0.95) .138
Sex, N (%)
Male 93 (44.9) 198 (31.1) <.001 68 (50.0) 254 (47.6) .612
Female 114 (55.1) 439 (68.9) 68 (50.0) 280 (52.4)
Level of educationa , N (%)
Low 69 (33.3) 208 (32.7) .856 82 (60.3) 297 (55.6) .326
High 138 (66.7) 429 (67.3) 54 (39.7) 237 (44.4)
(Parental) smokingb , N (%) 106 (51.2) 321 (50.4) .838 78 (57.4) 258 (48.4) .062
Allergic comorbidities, N (%)
Allergic rhinitis 190 (91.8) 376 (59.0) <.001 101 (74.3) 234 (43.8) <.001
Asthma 81 (39.1) 119 (18.7) <.001 54 (39.7) 145 (27.2) .004
Atopic dermatitis 55 (26.6) 179 (28.1) .669 89 (65.4) 288 (53.9) .016
Reproducibility of reactionc , N (%) 195 (95.6) 547 (88.1) .002 120 (90.9) 481 (92.3) .592
Time onset in minutes, median 
(Q1-Q3)
5 (1-15) 30 (10-120) <.001 5 (1.0-60.0) 60.0 (5.0-240.0) <.001
Symptomsd , N (%)
Oral allergy 169 (81.6) 214 (33.6) <.001 75 (55.1) 112 (21.0) <.001
Skin 79 (38.2) 259 (40.7) .524 108 (79.4) 345 (64.6) .001
Gastrointestinal 52 (25.1) 286 (44.9) <.001 38 (27.9) 205 (38.4) .024
Rhinoconjunctivitis 61 (29.5) 142 (22.3) .036 55 (40.4) 133 (24.9) <.001
Respiratory 44 (21.3) 71 (11.1) <.001 27 (19.9) 47 (8.8) <.001
Cardiovascular 15 (7.2) 79 (12.4) .041 6 (4.4) 18 (3.4) .560
Center, N (%)
Athens 5 (2.4) 17 (2.7) <.001 7 (5.1) 17 (3.2) .003
Lodz 26 (12.6) 88 (13.8) 30 (22.1) 174 (32.6)
Madrid 19 (9.2) 63 (9.9) 22 (16.2) 43 (8.1)
Reykjavik 21 (10.1) 189 (29.7) 26 (19.1) 128 (24.0)
Utrecht 60 (29.0) 139 (21.8) 28 (20.6) 78 (14.6)
Zurich 76 (36.7) 141 (22.1) 17 (12.5) 48 (9.0)
Vilnius - - 6 (4.4) 46 (8.6)
aLow level of education: None, primary school only, secondary school only or lower level vocational training. High level of education: higher level 
vocational training, university or full-time student. For children, the highest level of education of the best-educated parent was taken into account. 
bFor adults: “Ever smoked for at least one year?” For children: “Has either parent smoked at least 1 cigarette (or alternative) a day since the birth of 
the child?” 
cReproducibility of reaction: the reaction occurred more than once (reference = once). 
dOral allergy symptoms = itching, tingling or swelling of the mouth, lips or throat; Skin symptoms = rash, nettle sting or itchy skin; 
Rhinoconjunctivitis = runny or stuffy nose or red, sore or running eyes; Gastrointestinal symptoms = diarrhoea or vomiting; Respiratory 
symptoms = breathlessness; Cardiovascular symptoms = fainting or dizziness. 
*The P-values pertain to the comparison of the two preceding columns using the chi-square test, two-sample T test or Mann-Whitney U test as 
appropriate for the variable's distribution. 
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and to avoid overfitting, Least Absolute Shrinkage and Selection 
Operator (Lasso) regression was applied. Lasso regression is a form 
of penalized regression, in which only the most contributive vari-
ables are selected, and shrinkage of regression coefficients is applied 
through cross-validation, to arrive at a more generalizable model.8 
The area under the curve (AUC) of the receiver operating character-
istic (ROC) was calculated to evaluate the diagnostic value of both 
the full and penalized model.
We know from previous research that probable FA to plant 
source foods dominates in adults,3 but that both plant and animal 
source probable FA play important roles in school-age children.2 
Because the presentation of FA may depend on the type of food elic-
iting the reaction, patient history determinants of children with only 
plant source probable FA and of children with only animal source 
probable FA were compared univariably in an extra explorative 
analysis. The Lasso regression was then repeated in the source pop-
ulation of children with self-reported FA to plant source foods, and 
the outcome plant source probable FA was evaluated, as this con-
cerned the largest group of children and improved comparability to 
the adult population.




Of 862 adult subjects reporting symptoms to priority foods and 
completing phase II,3 the 844 with available serology were evaluated 




ORa  95%-CI Adjusted ORb  95%-CI
Crude 
ORa  95%-CI Adjusted ORb  95%-CI
Reaction characteristics
Time until onset (per 
30 min)
0.94 0.90-0.96 0.96 0.93-0.99 0.99 0.98-1.00 1.00 0.99-1.00
Reproducibility of 
reaction
2.93 1.52-6.39 3.24 1.41-8.33 0.83 0.44-1.70 0.75 0.34-1.72
Oral allergy 
symptoms
8.79 6.02-13.12 5.62 3.61-8.93 4.63 3.12-6.91 3.43 2.07-5.71
Skin symptoms 0.90 0.65-1.24 0.92 0.59-1.42 2.11 1.36-3.37 1.67 0.96-2.96
Gastrointestinal 
symptoms
0.41 0.29-0.58 0.59 0.38-0.90 0.62 0.41-0.93 0.86 0.52-1.42
Rhinoconjunctivitis 1.46 1.02-2.07 1.11 0.69-1.77 2.05 1.38-3.03 1.43 0.85-2.38
Respiratory 
symptoms
2.15 1.41-3.25 1.41 0.82-2.41 2.57 1.52-4.28 1.01 0.50-1.98
Cardiovascular 
symptoms
0.55 0.30-0.95 0.63 0.30-1.25 1.32 0.44-3.23 1.39 0.40-3.82
Allergic comorbidities
Allergic rhinitis 7.76 4.74-13.52 4.44 2.52-8.26 3.70 2.45-5.70 3.13 1.87-5.33
Asthma 2.80 1.98-3.94 1.88 1.21-2.95 1.77 1.19-2.61 1.20 0.71-2.02
Atopic dermatitis 0.93 0.65-1.31 0.74 0.47-1.16 1.62 1.10-2.41 1.36 0.85-2.22
Demographic factors
Age 0.98 0.96-1.00 0.98 0.96-1.00 1.16 0.95-1.42 0.99 0.78-1.26
Male sex 1.81 1.31-2.49 2.34 1.55-3.57 1.10 0.76-1.61 1.03 0.65-1.61
High level of 
education
0.97 0.70-1.36 1.01 0.64-1.59 0.83 0.56-1.21 0.93 0.57-1.50
(Parental) smoking 1.03 0.75-1.41 1.43 0.95-2.16 1.43 0.98-2.10 1.22 0.77-1.96
AUC 0.86 (0.83-0.89) 0.76 (0.71-0.82)
Note: Bold print: significant at P < .05.
Abbreviations: AUC, area under the receiver operating characteristic curve; CI, confidence interval; OR, Odds ratio.
aUnadjusted OR, results of univariable logistic regression analysis. 
bAdjusted OR, results of multivariable logistic regression analysis with all covariates included, that is the full model. Model coefficients were adjusted 
for center. 
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in this study. Positive IgE serology matching the food reported to 
cause symptoms was identified in 207/844 (25%) subjects, who 
were classified as having probable FA. Table 1 shows the population 
characteristics of these subjects. Most adults had probable FA to ha-
zelnut, followed by apple, peach, kiwi, carrot and walnut (Table S1).
Complete data on the predictor variables, as required for mul-
tivariable analyses, were available for 807 subjects. There were no 
significant differences in demographics, allergic comorbidities, or 
reaction characteristics between the subjects with complete data 
(N = 807) and the subjects with missing data on food serology or 
predictor variables (N = 55), except that subjects from certain cen-
ters were more likely to have complete data (Table S2).
Univariable analysis revealed that shorter time until onset of the 
reaction, reproducibility of the reaction and reporting of OAS, rhi-
noconjunctivitis or respiratory symptoms in response to the culprit 
food were statistically significantly (P < .05) associated with prob-
able FA, as were allergic comorbidities AR and asthma, and demo-
graphic factors younger age and male sex (Tables 1 and 2). Reporting 
of gastrointestinal (GI) symptoms and of potential cardiovascular 
symptoms (ie fainting or dizziness) were associated with not having 
probable FA.
In multivariable analyses, the combination of all predictor vari-
ables resulted in an AUC of 0.86 (95%-CI 0.83-0.89), implying good 
discriminative ability. Seven patient history predictors (reaction 
time, reproducibility of the reaction, OAS, GI symptoms, asthma, AR 
and sex) were found to independently and statistically significantly 
contribute to differentiation between presence or absence of prob-
able FA (Table 2). The strongest of these predictors were reporting 
of OAS and of AR comorbidity, with respective OR's of 5.62 (95%-CI 
3.61-8.93) and 4.44 (95%-CI 2.52-8.26).
The results from Lasso regression are presented in Figure 1. 
The same seven patient history variables were selected to optimally 
predict probable FA (Figure 1), though the ORs were less extreme 
and the AUC of this parsimonious model (based on cross-validation) 
was lower (0.85 (95%-CI 0.82-0.87)), as expected.
3.2 | Children
As regards the population of school-age children, 702 subjects with 
self-reported FA completed phase II,2 and 670 underwent food se-
rology testing. A total of 136/670 (20%) children were found to 
have probable FA (Table 1). Children were mostly allergic to cow's 
milk, hen's egg, hazelnut, peanut, apple, kiwi, peach and walnut 
(Table S1).
Multivariable analyses could be performed in 593 children with 
complete data on predictor variables. As seen in Table S2, the pop-
ulation characteristics of the children with complete data (N = 593) 
were not significantly different to those of children with missing 
data on food serology or predictor variables (N = 109).
Similarly to adults in univariable analyses, shorter time until 
onset of the reaction; OAS, rhinoconjunctivitis, or respiratory symp-
toms; and having comorbid AR or asthma, were significantly asso-
ciated with probable FA, and subjects reporting GI symptoms were 
less likely to have probable FA (Tables 1 and 2). In contrast to adults, 
reporting skin symptoms and having comorbid atopic dermatitis 
were positively and significantly associated with probable FA in chil-
dren, and reproducibility of the reaction, although not statistically 
significant, was inversely associated with probable FA. None of the 
demographic factors age, sex or level of education predicted prob-
able FA in children.
All patient history variables combined in multivariable analysis, 
yielded a full model with an AUC of 0.76 (0.71-0.82). Two variables, 
which were also the strongest predictors in adults, were statistically 
F I G U R E  1   Independent predictors 
of probable FA in individuals reporting 
food-related symptoms, results from 
Lasso regression analysis. 95% confidence 
intervals were calculated from standard 
errors obtained through 1000 bootstrap 
samples.GI, gastrointestinal; OA, oral 
allergy
0 1 2 3 4 5
Male sex (OR 1.50 [1.41-1.59])
Allergic Asthma (OR 1.38 [1.30-1.46])
Allergic Rhinitis (OR 2.82 [2.68-2.95])
GI symptoms (OR 0.88 [0.85-0.91])
OA symptoms (OR 4.46 [4.19-4.75])
Reproducibility (OR 1.35 [1.29-1.41])
Time onset (OR 1.00 [0.99-1.00])
Adults (AUC 0.85 [95%CI 0.82-0.87])
0 1 2 3 4 5
Allergic Rhinitis (OR 1.47 [1.39-1.55])
OA symptoms (OR 2.26 [2.09-2.44])
Odds Ratio [95% CI]
Children (AUC 0.73 [95%CI 0.68-0.78])
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significant for prediction of probable FA in children: OAS (OR 2.94 
[95%-CI 1.75-4.97]) and AR comorbidity (OR 3.39 [95%-CI 1.98-
5.91]) (Table 2). These two variables were also selected in the Lasso 
regression (Figure 1), which again resulted in less extreme ORs, and a 
lower cross-validation-based AUC of 0.73 (95% CI 0.68-0.78).
3.3 | Plant vs animal source causative foods 
in children
Although the vast majority of adults with probable FA were allergic 
to plant source foods (188/207, 91%), probable FA in children was 
frequently caused by animal source foods (62/136, 46%) as well as 
by plant source foods (92/136, 68%) (Table S1).
Table 3 shows that children with probable FA to only plant source 
foods (N = 74) reported OAS and AR comorbidity more often than 
children with probable FA to only animal source foods (N = 44). 
Furthermore, 58% of children with probable FA to animal source 
foods reported GI symptoms, compared with only 13% of children 
with probable FA to plant source foods.
When probable FA to plant source foods rather than to all pri-
ority foods was taken as the outcome of interest, in a source popu-
lation of children with self-reported FA to plant source foods, Lasso 
regression selected OAS (OR 1.69, 95% CI 1.57-1.82), rhinoconjunc-
tivitis symptoms (OR 1.08, 95% CI 1.04-1.13), GI symptoms (OR 
0.63, 95% CI 0.59-0.66) and AR comorbidity (OR 3.10, 95% CI 2.86-
3.37), as contributive predictors. The cross-validation-based AUC of 
this Lasso model focused on plant source probable FA, 0.81 (95% CI 
0.75-0.89), was more comparable to the AUC in adults, than the AUC 
of the Lasso model for predicting probable FA due to any priority 
food.
4  | DISCUSSION
Experts describe patient history as the most important single test 
for diagnosing FA.9 To our knowledge, the current study is the first 
to quantify the value of specific reported reaction characteristics 
(reaction time, reproducibility of reaction, symptoms) alongside al-
lergic comorbidities and demographic factors, for predicting IgE sen-
sitization corresponding to the culprit food, making FA probable. We 
also found that combining seven independent predictors (reaction 
time, reproducibility of reaction, OAS, GI symptoms, AR comorbid-
ity, asthma comorbidity and sex) in a prediction model, allowed for 
good discrimination between presence and absence of probable FA 
in adults, with an AUC after cross-validation of 0.85. For school-age 
children, OAS and AR comorbidity were found to be the most dis-
criminative combination of predictors for probable FA, with a com-
paratively lower AUC of 0.73, but which tended to improve when 
focusing solely on plant source causative foods, the main source of 
FA in adults.
Based on expert opinion, current guidelines state that timing, 
reproducibility, symptoms and co-existing allergic diseases should 
be addressed in patient history for FA.4,5,10 Our findings lend scien-
tific evidence in support of these recommendations. A shorter time 
until onset of a reaction, reporting of OAS, rhinoconjunctivitis or 
respiratory symptoms upon ingestion of the culprit food, and AR 
or asthma comorbidity, were positively associated with probable FA 
in both adults and children. However, predictors of probable FA in 
children contrasted with those in adults in that time until onset and 








N = 74 N = 44
Age, mean (SD) 9.2 (1.02) 8.7 (0.85) .017
Sex, N (%)
Male 37 (50.0) 22 (50.0) >.99
Female 37 (50.0) 22 (50.0)
Level of education parents, N (%)
Low 49 (66.2) 26 (59.1) .437
High 25 (33.8) 18 (40.9)
Parental smoking, N 
(%)
43 (58.1) 27 (61.4) .728
Allergic comorbidities, N (%)
Allergic rhinitis 62 (83.8) 23 (52.3) <.001
Asthma 27 (36.5) 17 (38.6) .815
Atopic dermatitis 44 (59.5) 29 (65.9) .485
Reproducibility of 
reaction, N (%)
61 (87.1) 41 (93.2) .306
Time onset in minutes, 
median (Q1-Q3)
5.0 (1.0-120.0) 15.0 (3.0-90.0) .404
Symptoms, N (%)
Oral allergy 45 (60.8) 15 (34.1) .005
Skin 60 (81.1) 32 (72.7) .290
Gastrointestinal 9 (12.2) 23 (52.3) <.001
Rhinoconjunctivitis 33 (44.6) 13 (29.5) .105
Respiratory 11 (14.9) 8 (18.2) .635
Cardiovascular 5 (6.8) 0 (0.0) .078
Center, N (%)
Athens 3 (4.1) 1 (2.3) .002
Lodz 16 (21.6) 11 (25.0)
Madrid 13 (17.6) 6 (13.6)
Reykjavik 7 (9.5) 16 (36.4)
Utrecht 15 (20.3) 8 (18.2)
Zurich 16 (31.6) 0 (0.0)
Vilnius 4 (5.4) 2 (4.5)
Note: In 18/136 children, both animal and plant source foods caused 
probable FA (Table S1). These subjects are excluded in this table.
*The P-values pertain to the comparison of the two preceding columns 
using the chi-square test, two-sample T test or Mann-Whitney U test 
as appropriate for the variables distribution. Exploratory analyses, not 
corrected for multiple testing. 
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reproducibility of the reaction were not independently associated 
with probable FA in the pediatric multivariable analyses, and that 
skin symptoms tended to be more strongly associated with probable 
FA in children than in adults. An explanation for these observations 
could be that parents may not pick up on their child's reaction until 
later, when objective symptoms (ie skin symptoms) appear. Parents 
are also likely to ensure strict avoidance of a food after a child expe-
riences a single adverse reaction, whereas adults may retry a food in 
case of mild symptoms, leading to reproducible reactions in adults 
and not in children. Another important difference between adults 
and children that affects which patient history determinants are as-
sociated with probable FA, is that adults are mainly allergic to plant 
source foods, whereas children are also likely to be allergic to animal 
source foods. Probable FAs to plant source foods rarely present with 
GI symptoms, whereas GI symptoms are often reported in relation 
to probable FA to animal source foods (Table 3). This observation 
explains why GI symptoms were inversely associated with probable 
FA in adults, but this association was only found in children when 
the analyses focused on plant source probable FA.
The strongest predictor of probable FA in both the adult and pe-
diatric population was reporting of OAS. Clinical experience teaches 
that this clearly identifiable symptom is generally the first symptom 
that subjects with an IgE-mediated reaction experience,11,12 though 
it is particularly associated with pollen-related FA. Pollen-related 
FA is a very common cause of FA in European adults and adoles-
cents and generally presents with mild OAS in reaction to raw fruits, 
vegetables and nuts that cross-react with pollen allergens to which 
the symptomatic individual is sensitized (most often PR10 proteins 
found in birch, or profilin found in all pollen).13,14 The majority of 
subjects in our study were from birch endemic regions in Central 
and Northern Europe. In order to evaluate the relative importance 
of OAS independently of birch pollen sensitization and the modifi-
cation of its predictive effect by birch pollen sensitization, we per-
formed an additional analysis. We added IgE sensitization to major 
birch pollen allergen Bet v 1,13 and an interaction between OAS and 
IgE sensitization to Bet v 1, to the full multivariable model. As ex-
pected, there was a statistically significant interaction between re-
porting of OAS and Bet v 1 sensitization in adults (P = .02). OAS was 
particularly predictive of FA in those with Bet v 1 sensitization (OR 
11.8 [95% CI 3.9-37.6]), and a less strong predictor in those without 
Bet v 1 sensitization (OR 2.6 [95% CI 1.4-4.9]). Nonetheless, OAS re-
mained a statistically significant independent predictor of probable 
FA in adults. As birch pollen-related FA is not yet as common in 7- to 
10-year-old children as in adults, it was not surprising that a similar 
interaction was not observed in children.
Although it goes beyond the scope of this paper to delve into 
geographical variation in the likelihood of probable FA, as this topic 
was extensively discussed in previous publications,2,3 it is worth not-
ing that the effect of center on probable FA in adults in multivari-
able analysis was strongest in countries known for high level of birch 
pollen sensitization (Switzerland, Poland and the Netherlands). The 
effect of center was no longer statistically significant after adjust-
ment for Bet v 1 sensitization in the full model. In Lasso regression 
analysis, only Switzerland, the EuroPrevall country with the most 
birch pollen sensitization,3 was selected as predictive of probable 
FA in adults. In the pediatric multivariable models, center was not a 
statistically significant predictor in the full model with all covariates 
included nor was it selected during Lasso regression. Apparently, 
most of the variation between centers in the pediatric population 
is explained by the other covariates included in the model (Table 2).
Previous studies taking the predictive value of patient history into 
account tend to focus only on severity of reported symptoms. In a 
pediatric outpatient population selected for food challenge in Ireland 
and the UK, DunnGalvin et al15 found that increasing severity of re-
ported symptoms increased the likelihood of challenge-confirmed 
peanut, milk and egg allergy. In a Dutch adult outpatient population, 
Klemans et al16 observed no statistically significant association be-
tween reported symptom severity and challenge-confirmed peanut 
allergy. For comparative purposes, we graded reported symptoms 
according to the severity classification used by DunnGalvin et al,15 
in an additional analysis (Table S3). Similarly to DunnGalvin et al, the 
likelihood of probable FA tended to increase with increasing symptom 
severity in children in our study, though the trend was less clear in 
adults. Interestingly, our model with specific symptoms included in-
dependently (Table 2) rather than grouped in severity classifications 
(Table S3), was significantly better at discriminating between presence 
and absence of probable FA, specifically in adults (AUC = 0.86 [95% CI 
0.83-0.89) vs 0.81 [0.78-0.84], PDe Long's test < .001 in adults; and AUC 
0.76 [0.71-0.82] vs 0.73 [0.68-0.79], PDe Long's test = .43 in children).
The high predictive ability of our multivariable models for prob-
able FA in adults, which combine reaction time, reproducibility of 
reaction, OAS, GI symptoms, AR comorbidity, asthma comorbidity 
and sex, may be useful in clinical practice. Our parsimonious model 
corrected for overfitting (Figure 1) aimed to be more generalizable 
to the general population of patients with food-related complaints 
(Table 2). Details for the prediction formula and accuracy measures 
corresponding to specific cut-offs of the formula's outcome score 
are available in Tables S4 and S5. Of particular interest is the high 
negative predictive value of the prediction formula. If all adults with 
a prediction score smaller than 0.17 (= 46% of the population) were 
to be classified as not having probable FA, 95% of these adults would 
indeed not have a probable FA. This might be of interest to GPs for 
identifying adults in whom to conduct further IgE sensitization test-
ing, although formal validation of this formula should probably be 
performed before it can be used as such.
Although there were no food challenge outcomes available to as-
sess the diagnostic value of patient history by comparing it to the refer-
ence standard for diagnosis of FA, our findings from prediction analyses 
yield essential evidence on the value of patient history in support of 
clinical practice. Our findings for probable FA are in line with expec-
tations from expert opinion, according to which timing, reproducibil-
ity, symptoms and co-existing allergic diseases should be addressed in 
patient history for FA.4,5,10 The individual weights provided for these 
patient history determinants of probable FA in the current study, may in 
the future inform physicians' decision-making in daily practice, particu-
larly to help avoid unnecessary IgE testing in adults reporting adverse 
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reactions to (mainly plant source) foods. All in all, our findings reinforce 
the value of patient history in the diagnostic workup of FA.
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